Difference between revisions of "Part:BBa K3846360"
Crisprcaspr (Talk | contribs) |
|||
Line 3: | Line 3: | ||
<partinfo>BBa_K3846360 short</partinfo> | <partinfo>BBa_K3846360 short</partinfo> | ||
− | + | ===Mevalonate pathway=== | |
+ | The synthesis of sesquiterpenes, our main focus of this project, relies on the availability of common building blocks like farnesyl diphosphate (FPP). It has been shown for different organisms that the amount of FPP can be increased by overexpressing proteins of the mevalonat (MevT) and the MBIS pathway which we organised to be expressed into operon structures for our project. | ||
+ | Both operons are IPTG-inducible and use lacUV5 promoter and rrnB T1 and T2 terminator sequence. | ||
+ | |||
+ | <b>MevT operon</b>: | ||
+ | This operon contains the acetoacetyl-CoA synthase (ackA), HMG-CoA synthases (HMG), and an N-terminally truncated version of HMG-CoA reductase (tHMGR). | ||
+ | |||
+ | <b>MBIS operon</b>: | ||
+ | This operon contains mevalonate kinase (MK), phosphomevalonate kinase (PMK), phosphomevalonate decarboxylase (PMD), isopentenyl diphosphate isomerase (idi), and farnesyl diphosphate synthase (ispA). | ||
+ | |||
+ | By combining both of these operons in a single composite part and further adding synthases, it is possible to synthesize different bioactive compounds. | ||
+ | |||
+ | |||
+ | ===Humulene=== | ||
+ | Humulene is the precursor of the sesquiterpene ketone zerumbone, which has immunoregulatory and anticancer activities. The biosynthesis of cyclic sesquiterpenes is catalysed by FPP. In the case of humulene biosynthesis, this cyclase is alpha humulene synthase. | ||
+ | |||
+ | ===BBa:K3846360=== | ||
+ | This part combines the MevT and MBIS operons and the alpha humulene synthase expression cassette to produce alpha-humulene. | ||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here |
Revision as of 11:53, 20 October 2021
Alpha-humulen production casette
Mevalonate pathway
The synthesis of sesquiterpenes, our main focus of this project, relies on the availability of common building blocks like farnesyl diphosphate (FPP). It has been shown for different organisms that the amount of FPP can be increased by overexpressing proteins of the mevalonat (MevT) and the MBIS pathway which we organised to be expressed into operon structures for our project. Both operons are IPTG-inducible and use lacUV5 promoter and rrnB T1 and T2 terminator sequence.
MevT operon: This operon contains the acetoacetyl-CoA synthase (ackA), HMG-CoA synthases (HMG), and an N-terminally truncated version of HMG-CoA reductase (tHMGR).
MBIS operon: This operon contains mevalonate kinase (MK), phosphomevalonate kinase (PMK), phosphomevalonate decarboxylase (PMD), isopentenyl diphosphate isomerase (idi), and farnesyl diphosphate synthase (ispA).
By combining both of these operons in a single composite part and further adding synthases, it is possible to synthesize different bioactive compounds.
Humulene
Humulene is the precursor of the sesquiterpene ketone zerumbone, which has immunoregulatory and anticancer activities. The biosynthesis of cyclic sesquiterpenes is catalysed by FPP. In the case of humulene biosynthesis, this cyclase is alpha humulene synthase.
BBa:K3846360
This part combines the MevT and MBIS operons and the alpha humulene synthase expression cassette to produce alpha-humulene.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 9575
Illegal NheI site found at 9579 - 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]